Latest Insider Transactions at Insmed Inc (INSM)
This section provides a real-time view of insider transactions for Insmed Inc (INSM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INSMED Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INSMED Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 30
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
91,140
-48.42%
|
$7,291,200
$80.0 P/Share
|
|
Jan 30
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
91,140
+21.65%
|
$1,275,960
$14.92 P/Share
|
|
Jan 15
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-0.95%
|
$478,100
$70.24 P/Share
|
|
Jan 15
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
Jan 15
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
31,805
-2.62%
|
$2,226,350
$70.25 P/Share
|
|
Jan 15
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+4.36%
|
$412,500
$22.76 P/Share
|
|
Jan 14
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
872
-0.89%
|
$59,296
$68.72 P/Share
|
|
Jan 14
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,457
-0.99%
|
$99,076
$68.72 P/Share
|
|
Jan 14
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,384
-1.36%
|
$94,112
$68.72 P/Share
|
|
Jan 10
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,902
-1.62%
|
$308,826
$63.74 P/Share
|
|
Jan 10
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
2,978
-0.75%
|
$187,614
$63.36 P/Share
|
|
Jan 10
2025
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
287
-0.23%
|
$18,655
$65.4 P/Share
|
|
Jan 10
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
4,057
-2.0%
|
$255,591
$63.74 P/Share
|
|
Jan 10
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,066
-0.89%
|
$67,158
$63.72 P/Share
|
|
Jan 10
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,172
-2.89%
|
$388,836
$63.67 P/Share
|
|
Jan 10
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
319
-0.45%
|
$20,097
$63.38 P/Share
|
|
Jan 08
2025
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,657
+4.18%
|
-
|
|
Jan 08
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,882
-1.27%
|
$124,212
$66.1 P/Share
|
|
Jan 08
2025
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
22,824
+5.46%
|
-
|
|
Jan 08
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
3,999
-1.06%
|
$259,935
$65.96 P/Share
|
|
Jan 08
2025
|
John Drayton Wise Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,657
+5.02%
|
-
|
|
Jan 08
2025
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
392
-0.33%
|
$25,872
$66.21 P/Share
|
|
Jan 08
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,706
+5.3%
|
-
|
|
Jan 08
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,209
-1.24%
|
$78,585
$65.84 P/Share
|
|
Jan 08
2025
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,657
+5.26%
|
-
|
|
Jan 08
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,464
-1.28%
|
$96,624
$66.05 P/Share
|
|
Jan 08
2025
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,657
+5.82%
|
-
|
|
Jan 08
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,702
-1.66%
|
$112,332
$66.16 P/Share
|
|
Jan 08
2025
|
Michael Alexander Smith Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,706
+7.51%
|
-
|
|
Jan 08
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,064
-1.62%
|
$70,224
$66.21 P/Share
|
|
Jan 07
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,444
-1.63%
|
$158,860
$65.95 P/Share
|
|
Jan 07
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
8,218
-2.13%
|
$542,388
$66.02 P/Share
|
|
Jan 07
2025
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
12,908
-4.96%
|
$839,020
$65.93 P/Share
|
|
Jan 07
2025
|
John Drayton Wise Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.02%
|
$160,000
$16.07 P/Share
|
|
Jan 07
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
2,596
-2.59%
|
$168,740
$65.88 P/Share
|
|
Jan 07
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,470
-2.94%
|
$225,550
$65.7 P/Share
|
|
Jan 07
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,344
-3.15%
|
$217,360
$65.91 P/Share
|
|
Jan 07
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,306
-3.39%
|
$149,890
$65.98 P/Share
|
|
Jan 02
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-2.84%
|
$471,270
$69.86 P/Share
|
|
Jan 02
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
Jan 02
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
18,750
-4.64%
|
$1,293,750
$69.84 P/Share
|
|
Jan 02
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+4.44%
|
$412,500
$22.76 P/Share
|
|
Dec 19
2024
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-1.43%
|
$478,100
$70.16 P/Share
|
|
Dec 19
2024
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
Dec 19
2024
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
18,750
-2.35%
|
$1,312,500
$70.08 P/Share
|
|
Dec 19
2024
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+4.44%
|
$412,500
$22.76 P/Share
|
|
Dec 12
2024
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-0.95%
|
$498,590
$73.45 P/Share
|
|
Dec 12
2024
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
Dec 12
2024
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
18,750
-1.57%
|
$1,368,750
$73.46 P/Share
|
|
Dec 12
2024
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+4.44%
|
$412,500
$22.76 P/Share
|